Author Archives: Scalper1

Amgen, Regeneron Upgraded On Cholesterol Drug Promise

Amgen (AMGN) and Regeneron Pharmaceuticals (REGN) were both up Tuesday on upgrades from UBS after a survey suggested sales of their new cholesterol drugs could be even bigger than expected. Analyst Matthew Roden raised his rating on Regeneron all the way to buy from sell, and on Amgen to buy from neutral, after surveying 50 U.S. and European physicians about their attitudes toward the new PCSK9 inhibitors both companies have launched this summer.

What’s a fair price for Fitbit stock: $10 or $58?

Fitbit (FIT) stock jumped on Tuesday after Morgan Stanley upgraded the maker of wearable activity trackers. But others are bearish on Fitbit. Global Equities Research sounded the sell alarm Tuesday for the fitness band leader. Morgan Stanley analyst Katy Huberty upgraded Fitbit stock to overweight from equal weight and raised her price target to 58 from 43. Fitbit stock was up 8%, near 34.50, in morning trading on the stock market today. In a